Oral Antihistamines Don’t Meaningfully Help Eczema

A recent study of over 6000 children and adults with eczema found that some antihistamines that cause sleepiness are not as effective in decreasing eczema itch or flares.
At a Glance: Antihistamines for Atopic Dermatitis (Eczema)
- Atopic dermatitis(eczema) is a chronic skin condition that causes itchy, inflamed skin. It can affect both children and adults and may have a major impact on sleep, quality of life, mental health, and daily activities.
- Eczema is common. The study reports that atopic dermatitis affects 13% of children 7% of adults.
- Antichistamines are used for eczema, but they may not provide meaningful relief. Researchers reviewed 47 clinical trials involving 6,320 children and adults with mainly moderate-to-severe eczema to evaluate the benefits and risks of oral antihistamines.
- Antihistamines may slightly reduce itching and eczema severity, but the improvement is usually too small for most people to notice. Although the studies found measurable reductions in symptoms, the benefits were below the level considered clinically important.
- Antihistamines may not improve sleep problems or prevent eczema flare-ups. The review found low-certainty evidence that these medicines may not help with sleep disturbance or reduce eczema exacerbations.
- Some antihistamines can cause side effects that affect thinking and alertness. First-generation antihistamines, such as diphenhydramine and hydroxyzine, were linked to increased cognitive impairment and may increase the chance of stopping treatment because of side effects. The risk of cognitive impairment varies among second-generation antihistamines.
- Routine antihistamine use is not supported by this research. The study concluded that, for most people with atopic dermatitis, the small potential benefits do not outweigh the limited effectiveness and possible harms of these medicines.
Antihistamine Treatment for Atopic Dermatitis (Eczema)
This study is important because antihistamines are commonly used by people with eczema to help manage itching, yet this large review found that they provide little meaningful benefit for most patients. After analyzing 47 clinical trials involving 6,230 children and adults with atopic dermatitis, researchers concluded that antihistamines may slightly reduce itch and skin symptoms, but the improvements are generally too small for patients to notice.
The study also found that some antihistamines, particularly older first-generation medications, can cause side effects such as cognitive impairment. These findings help patients, caregivers, and healthcare providers make more informed treatment decisions and support focusing on therapies that are more effective for managing eczema symptoms,

Key Takeaways from the Antihistimine and Eczema Study
- Antihistamines are unlikely to provide meaningful relief for most people with eczema. While they may slightly reduce itching and eczema severity, the improvements are generally too small for patients to notice in daily life.
- Eczema itch is not driven primarily by histamine. Current research suggests that the itch associated with atopic dermatitis involves pathways beyond histamine, which may help explain why antihistamines do not work well for many patients
- Antihistamines may not improve sleep or prevent flare-ups. Despite their common use to help people sleep when eczema is itchy, the evidence suggests these medicines may not meaningfully reduce sleep disturbances or eczema exacerbations.
- Older, first-generation antihistamines can have important side effects. Medications such as diphenhydramine and hydroxyzine may cause cognitive impairment, sedation, and other adverse effects that can affect daily functioning
- Treatment decisions should balance limited benefits against potential risks. The study found that the small symptom improvements seen with antihistamines may not outweigh the possibility of side effects, particularly with first-generation products.
- Patients and healthcare providers may need to focus on other eczema treatments. The authors concluded that the evidence does not support routine antihistamine use in the management of atopic dermatitis, reinforcing the importance of using treatments that target the underlying causes of eczema.
Antihistamines for atopic dermatitis (eczema): systematic review and network meta-analysis of randomised trials
Chu, A.W.L., Guyatt, G.H.,Bakaa, L., ….. Gardner, D.D., ..Chu, D.K
2026
BMJ
DOI: 10.1136/bmj-2026-100163














